194 related articles for article (PubMed ID: 20876384)
1. Molecular determinants of human ether-à-go-go-related gene 1 (hERG1) K+ channel activation by NS1643.
Grunnet M; Abbruzzese J; Sachse FB; Sanguinetti MC
Mol Pharmacol; 2011 Jan; 79(1):1-9. PubMed ID: 20876384
[TBL] [Abstract][Full Text] [Related]
2. PD-118057 contacts the pore helix of hERG1 channels to attenuate inactivation and enhance K+ conductance.
Perry M; Sachse FB; Abbruzzese J; Sanguinetti MC
Proc Natl Acad Sci U S A; 2009 Nov; 106(47):20075-80. PubMed ID: 19892732
[TBL] [Abstract][Full Text] [Related]
3. Structural basis of action for a human ether-a-go-go-related gene 1 potassium channel activator.
Perry M; Sachse FB; Sanguinetti MC
Proc Natl Acad Sci U S A; 2007 Aug; 104(34):13827-32. PubMed ID: 17693551
[TBL] [Abstract][Full Text] [Related]
4. A single amino acid difference between ether-a-go-go- related gene channel subtypes determines differential sensitivity to a small molecule activator.
Perry M; Sanguinetti MC
Mol Pharmacol; 2008 Apr; 73(4):1044-51. PubMed ID: 18162604
[TBL] [Abstract][Full Text] [Related]
5. Structure-guided topographic mapping and mutagenesis to elucidate binding sites for the human ether-a-go-go-related gene 1 potassium channel (KCNH2) activator NS1643.
Durdagi S; Guo J; Lees-Miller JP; Noskov SY; Duff HJ
J Pharmacol Exp Ther; 2012 Aug; 342(2):441-52. PubMed ID: 22573844
[TBL] [Abstract][Full Text] [Related]
6. Activation of human ether-a-go-go-related gene potassium channels by the diphenylurea 1,3-bis-(2-hydroxy-5-trifluoromethyl-phenyl)-urea (NS1643).
Hansen RS; Diness TG; Christ T; Demnitz J; Ravens U; Olesen SP; Grunnet M
Mol Pharmacol; 2006 Jan; 69(1):266-77. PubMed ID: 16219910
[TBL] [Abstract][Full Text] [Related]
7. C-Linker Accounts for Differential Sensitivity of ERG1 and ERG2 K+ Channels to RPR260243-Induced Slow Deactivation.
Gardner A; Sanguinetti MC
Mol Pharmacol; 2015 Jul; 88(1):19-28. PubMed ID: 25888115
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of action of a novel human ether-a-go-go-related gene channel activator.
Casis O; Olesen SP; Sanguinetti MC
Mol Pharmacol; 2006 Feb; 69(2):658-65. PubMed ID: 16284303
[TBL] [Abstract][Full Text] [Related]
9. NS1643 interacts around L529 of hERG to alter voltage sensor movement on the path to activation.
Guo J; Cheng YM; Lees-Miller JP; Perissinotti LL; Claydon TW; Hull CM; Thouta S; Roach DE; Durdagi S; Noskov SY; Duff HJ
Biophys J; 2015 Mar; 108(6):1400-1413. PubMed ID: 25809253
[TBL] [Abstract][Full Text] [Related]
10. Molecular determinants for activation of human ether-à-go-go-related gene 1 potassium channels by 3-nitro-n-(4-phenoxyphenyl) benzamide.
Garg V; Stary-Weinzinger A; Sachse F; Sanguinetti MC
Mol Pharmacol; 2011 Oct; 80(4):630-7. PubMed ID: 21743002
[TBL] [Abstract][Full Text] [Related]
11. Concatenated hERG1 tetramers reveal stoichiometry of altered channel gating by RPR-260243.
Wu W; Gardner A; Sanguinetti MC
Mol Pharmacol; 2015; 87(3):401-9. PubMed ID: 25519838
[TBL] [Abstract][Full Text] [Related]
12. Strong activation of ether-à-go-go-related gene 1 K+ channel isoforms by NS1643 in human embryonic kidney 293 and Chinese hamster ovary cells.
Schuster AM; Glassmeier G; Bauer CK
Mol Pharmacol; 2011 Nov; 80(5):930-42. PubMed ID: 21856740
[TBL] [Abstract][Full Text] [Related]
13. Probing the binding sites and mechanisms of action of two human ether-a-go-go-related gene channel activators, 1,3-bis-(2-hydroxy-5-trifluoromethyl-phenyl)-urea (NS1643) and 2-[2-(3,4-dichloro-phenyl)-2,3-dihydro-1H-isoindol-5-ylamino]-nicotinic acid (PD307243).
Xu X; Recanatini M; Roberti M; Tseng GN
Mol Pharmacol; 2008 Jun; 73(6):1709-21. PubMed ID: 18372399
[TBL] [Abstract][Full Text] [Related]
14. Biophysical characterization of the new human ether-a-go-go-related gene channel opener NS3623 [N-(4-bromo-2-(1H-tetrazol-5-yl)-phenyl)-N'-(3'-trifluoromethylphenyl)urea].
Hansen RS; Diness TG; Christ T; Wettwer E; Ravens U; Olesen SP; Grunnet M
Mol Pharmacol; 2006 Oct; 70(4):1319-29. PubMed ID: 16825484
[TBL] [Abstract][Full Text] [Related]
15. Structure driven design of novel human ether-a-go-go-related-gene channel (hERG1) activators.
Guo J; Durdagi S; Changalov M; Perissinotti LL; Hargreaves JM; Back TG; Noskov SY; Duff HJ
PLoS One; 2014; 9(9):e105553. PubMed ID: 25191697
[TBL] [Abstract][Full Text] [Related]
16. Kinetic model for NS1643 drug activation of WT and L529I variants of Kv11.1 (hERG1) potassium channel.
Perissinotti LL; Guo J; De Biase PM; Clancy CE; Duff HJ; Noskov SY
Biophys J; 2015 Mar; 108(6):1414-1424. PubMed ID: 25809254
[TBL] [Abstract][Full Text] [Related]
17. Molecular Basis of Altered hERG1 Channel Gating Induced by Ginsenoside Rg3.
Gardner A; Wu W; Thomson S; Zangerl-Plessl EM; Stary-Weinzinger A; Sanguinetti MC
Mol Pharmacol; 2017 Oct; 92(4):437-450. PubMed ID: 28705808
[TBL] [Abstract][Full Text] [Related]
18. NS1643 enhances ionic currents in a G604S-WT hERG co-expression system associated with long QT syndrome 2.
Huo J; Guo X; Lu Q; Qiang H; Liu P; Bai L; Huang CL; Zhang Y; Ma A
Clin Exp Pharmacol Physiol; 2017 Nov; 44(11):1125-1133. PubMed ID: 28741726
[TBL] [Abstract][Full Text] [Related]
19. Potent activation of large-conductance Ca2+-activated K+ channels by the diphenylurea 1,3-bis-[2-hydroxy-5-(trifluoromethyl)phenyl]urea (NS1643) in pituitary tumor (GH3) cells.
Wu SN; Peng H; Chen BS; Wang YJ; Wu PY; Lin MW
Mol Pharmacol; 2008 Dec; 74(6):1696-704. PubMed ID: 18809671
[TBL] [Abstract][Full Text] [Related]
20. The Pore-Lipid Interface: Role of Amino-Acid Determinants of Lipophilic Access by Ivabradine to the hERG1 Pore Domain.
Perissinotti L; Guo J; Kudaibergenova M; Lees-Miller J; Ol'khovich M; Sharapova A; Perlovich GL; Muruve DA; Gerull B; Noskov SY; Duff HJ
Mol Pharmacol; 2019 Aug; 96(2):259-271. PubMed ID: 31182542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
